Sponsor pipeline

Adverum Biotechnologies, Inc. clinical trial pipeline

Get alerts when Adverum Biotechnologies, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 2
2
Phase 3
2
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07482176 Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With… Neovascular Age-Related Macular Degeneration (nAMD) Recruiting 2026-09-24
NCT06856577 Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With… Neovascular Age-Related Macular Degeneration (nAMD) Active, Not Recruiting 2026-05-22
Phase 2
NCT07630649 Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With… Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD Recruiting 2026-08-05
NCT05536973 Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular… Neovascular Age-related Macular Degeneration Active, Not Recruiting 2025-08-22
Not specified
NCT04645212 Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT] Wet Age-related Macular Degeneration Active, Not Recruiting 2026-02-10
NCT05607810 Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT) Diabetic Macular Edema Active, Not Recruiting 2025-04-22

Disease areas by active trials

Diabetes (1)

Get alerts when Adverum Biotechnologies, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free